4.7 Article

Facile imprinted polymer for label-free highly selective potentiometric sensing of proteins: case of recombinant human erythropoietin

Journal

ANALYTICAL AND BIOANALYTICAL CHEMISTRY
Volume 413, Issue 14, Pages 3611-3623

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00216-021-03325-4

Keywords

Recombinant human erythropoietin; Label-free sensor; Ion selective electrode; Artificial antibody; Molecularly imprinted electrode; Potentiometric sensor

Ask authors/readers for more resources

A molecularly imprinted polymer (MIP)-based potentiometric sensor was developed for label-free determination of recombinant human erythropoietin (rhEPO) in the current study. The sensor demonstrated specificity for rhEPO and could be used for the determination of rhEPO in various biopharmaceutical formulations.
In the current study, a molecularly imprinted polymer (MIP)-based potentiometric sensor was fabricated for a label-free determination of recombinant human erythropoietin (rhEPO). The MIP sensor was operated under zero current conditions using tetra-butyl ammonium bromide as a marker ion. A highly ordered rhEPO surface imprinted layer was prepared using 3-aminopropyl triethoxysilane and tetraethoxysilane as a monomer and cross-linker, respectively, under mild reaction conditions. A two-fold increase in the signal output was obtained by polymeric surface minimization (0.5 mm) that allowed more pronounced molecular recognition (imprinting factor = 20.1). The proportion of cross-reactivity was examined using different interfering biomolecules. Results confirmed sensor specificity for both structurally related and unrelated proteins. An similar to 40% decrease in the response was obtained for rhEPO-beta compared to rhEPO-alpha. The imprinted polymeric surface was evaluated using scanning electron microscopy and Fourier transform infrared spectroscopy. Under the optimal measurement conditions, a linear range of 10.00-1000.00 ng mL(-1) (10(-10) - 10(-8) M) was obtained. The sensor was employed for the determination of rhEPO in different biopharmaceutical formulations. Results were validated against standard immunoassay. Spiked human serum samples were analyzed and the assay was validated. The presence of non-specific proteins did not significantly affect (similar to 8%) the results of our assay. A concentration-dependent linear response was produced in an identical range with detection limit as low as 6.50 ng mL(-1) (2.14 x 10(-10) M). The facile fabricated MIP sensor offers a cost-effective, portable, and easy to use alternative for biosimilarity assessment and clinical application.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available